The League of European Research Universities has once again hit out at IP rules and funding levels in the EU’s Innovative Medicines Initiative, saying academics will be discouraged from taking part in the €2B collaborative research programme
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.